Clinical Trials

In a bid to ensure transparency and clarity in their drug approval decisions,  U.S FDA Commissioner Scott Gottlieb endeavors to undertake new drug innovation and Scientific progress by…
Read More...

Ophthotech Corporation enrolled first patient in the Phase 2b randomized, double-masked, sham-controlled clinical trial assessing the efficacy and safety of Zimura complement C5…
Read More...

Ipsen and Exelixis declared results of Phase 3 CELESTIAL trial in  patients formerly treated with advanced heptacellular carcinoma. In CELESTIAL, cabozantinib provided a statistically…
Read More...

Utilizing advanced analytics to offer workflow solutions and apps that advocate support solutions paving way for undisputed integration and analysis of in-vivo and in-vitro data, …
Read More...

Global biotech company committed to delivering transformative therapies to patients with orphan dermatologic and other underserved conditions, Castle Creek Pharmaceuticals confirmed…
Read More...

Celgene Corporation and Impact Biomedicinessigned and agreement that entails acquisition of Impact Biomedicines enabling development of fedratinib  for myelofibrosis and polycythemia…
Read More...

Following the league of leading in the markets of  clinical research organizations, Optimapharm obtained Czech CRO company MKS research. Following the acquisition , Optimapharm will…
Read More...

Clinical Biopharmaceutical Company Rgenix declared the Clinical and pre-Clinical results by research collaborators at Rgenix and Rockefeller University disclosing that Liver-X…
Read More...

This is to be brought to notice that WaveForm Technologies has successfully completed its four clinical Trials for its proprietary continuous glucose monitoring system. Patients are…
Read More...

The Medical Ethical Review Committee sought the Xcede Patch clinical trial dossier to initiate first-in-human clinical trial that eyes the treatment of up to 30 patients encountering…
Read More...

After the Bone, Reproductive and Urologic Drugs Advisory Committee ("BRUDAC") of the U.S. Food and Drug Administration ("FDA") voted six in favor and thirteen against the benefit/risk…
Read More...

Biodegradable balloon spacers, BioProtect announces the launch of Clinical Trial followed by the FDA approval for Investigational Device Exemption in November , 2017 that seeks to…
Read More...

Clinical stage biopharmaceutical company, SAB Biotherapeutics declared its phase 1 Clinical Trial results for treating MERS, a study that was undertaken by National Institutes of…
Read More...

GT Biopharma announces the successful completion of dosing in its phase 1 clinical trial for GTP-004 that claims to treat Myasthenia gravis. GTP-004 ensures safe administration of…
Read More...

Emotional Brain finally declares the successful Phase 2B results for its products Lybrido and Lybridos that were tested in 497 women suffering from Female sexual interest and Arousal…
Read More...

Bell Biosystems declared the results of their latest preclinical safety study at the Biotech Showcase in San Francisco. The study managed to comply with USP <151> pyrogenicity…
Read More...

Aimmune Therapeutics announced its plans for the upcoming year to report top-line results in February from a pivotal phase 3 PALISADE trial of AR101 for peanut allergy following the…
Read More...

Novaliq announces randomizing patients in its SEECASE Phase 2 clinical trial of NOV03 for treating dry eye disease. Novaliq is a pharmaceutical company delivering drugs that transforms…
Read More...

After successful completion of pre-clinical safety studies for MIV-818 which is Medivir AB’s liver targeted nucleotide prodrug for diagnosing hepatocellular carcinoma and other forms of…
Read More...

Semnur Pharmaceuticals announced the commencement of phase 3 clinical trials in the U.S to evaluate its product SP-102 in patients suffering from lumbar radicular pain/sciatica. It is…
Read More...